Baylosis, Jona .
HRN: 23-20-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2023
CEFUROXIME 500MG (TAB)
06/25/2023
07/02/2023
PO
500mg
BID X 7 Days
S/P Primary LTCS
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes